SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-3.5
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex3-5.htm

Chunk 2 of 3
Word Count: 1104
Character Count: 7030

Document Content:

as the same exists or hereafter may be amended. If the DGCL is amended after approval by the stockholders of this Article SIXTH to authorize corporate action further eliminating or limiting the personal liability of directors or officers, then the liability of a director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL as so amended, automatically and without further action, upon the date of such amendment. Neither any amendment nor repeal of this Article SIXTH, nor the adoption by amendment of this Certificate of Incorporation of any provision inconsistent with this Article SIXTH, shall eliminate or reduce the effect of this Article SIXTH in respect of any matter occurring, or any action or proceeding accruing or arising (or that, but for this Article SIXTH, would accrue or arise) prior to such amendment or repeal or adoption of an inconsistent provision.

SEVENTH:
The Corporation, to the fullest extent permitted by Section 145 of the DGCL, as amended from time to time, shall indemnify all persons
whom it may indemnify pursuant thereto. Expenses (including, without limitation, attorneys’ fees) incurred by an officer or director
in defending any civil, criminal, administrative, or investigative action, suit or proceeding for which such officer or director may
be entitled to indemnification hereunder shall be paid by the Corporation in advance of the final disposition of such action, suit or
proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be
determined that he is not entitled to be indemnified by the Corporation as authorized hereby. Any repeal or modification of this Article
SEVENTH by the stockholders of the Corporation or any repeal or modification of the relevant provisions of the DGCL shall not adversely
affect any right or protection of a person or entity entitled to indemnification hereunder with respect to events occurring prior to
the time of such repeal or modification. For purposes of this Article SEVENTH, references to “the Corporation” shall include,
in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation
or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees,
fiduciaries and agents, so that any person or entity who is or was a director, officer, employee, fiduciary or agent of such constituent
corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee, fiduciary or agent
of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this SEVENTH with
respect to the resulting or surviving corporation as he, she or it would have with respect to such constituent corporation if its separate
existence had continued. The rights to indemnification and the payment of expenses incurred in defending a proceeding in advance of its
final disposition conferred in this Article SEVENTH shall not be exclusive of any other right which any person or entity may have or
hereafter acquire under any statute, provision of this certificate of incorporation, bylaw, agreement, vote of stockholders or disinterested
directors or otherwise.

EIGHTH: To
the fullest extent permitted by applicable law, the Corporation is authorized to provide indemnification of (and advancement expenses
to) directors, officers and agents of the Corporation (and any other persons to which General Corporation Law permits the Corporation
to provide indemnification) through Bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested
directors or otherwise, in excess of the indemnification and advancement otherwise permitted by Section 145 of the General Corporation
Law. Any amendment, repeal or modification of the foregoing provisions of this Article EIGHTH shall not (a) adversely affect any right
or protection of any director, officer or other agent of the Corporation existing at the time of such amendment, repeal or modification
or (b) increase the liability of any director of the Corporation with respect to any acts or omissions of such director, officer or agent
occurring prior to, such amendment, repeal or modification.

NINTH: Whenever
a compromise or arrangement is proposed between the Corporation and its creditors or any class of them and/or between the Corporation
and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in
a summary way of the Corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed
for the Corporation under Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver
or receivers appointed for the Corporation under Section 279 of Title 8 of the Delaware Code order a meeting of the creditors or class
of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the case may be, to be summoned in such manner
as the said court directs. If a majority in number representing three fourths in value of the creditors or class of creditors, and/or
of the stockholders or class of stockholders of the Corporation, as the case may be, agree to any compromise or arrangement and to any
reorganization of the Corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said
reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class
of creditors, and/or on all the stockholders or class of stockholders, of the Corporation, as the case may be, and also on the Corporation.

TENTH: Except
to the extent expressly set forth in Articles SIXTH and SEVENTH, and EIGHTH, the Corporation reserves the right to amend, alter, change
or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all
rights conferred on stockholders herein are granted subject to this reservation.

That the foregoing amendment and restatement was approved by the holders of the requisite number of shares of this Corporation in
accordance with Section 228 of the DGCL.

That this Amended and Restated Certificate of Incorporation, which restates and integrates and further amends the provisions of this
Corporation’s Certificate of Incorporation, has been duly adopted in accordance with Sections 242 and 245 of the Delaware
General Corporation Law.

[Signature
Page Follows]

WITNESS WHEREOF, this Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of this Corporation
on this _____ day of [____________], 2025.

BIOVENTRIX, INC.

Name:	David
Richmond

Title:	Chief
Executive Officer